-+ 0.00%
-+ 0.00%
-+ 0.00%

Artiva Biotherapeutics Estimates $10M-$15M In Contract Termination And Other Costs For AlloNK Trials; Estimates $17M-$20M In Costs Related To Workforce Reduction

Benzinga·11/09/2026 22:20:04

-SEC Filing